Status:
COMPLETED
LQT and Smartphone/Smartwatch
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Long QT Syndrome
Eligibility:
All Genders
Brief Summary
Congenital long QT syndrome (LQTS) is a rare genetic disorder characterized by prolongation of the corrected QT interval (QTc) on the electrocardiogram. LQTS is associated with a risk of syncope or su...
Eligibility Criteria
Inclusion
- Patient with diagnosis of LQTS based on the following criteria:
- Corrected QT (Qtc) interval according to Bazett method ≥ 480 ms, at several times in the absence of a secondary cause
- and / or class 4 or 5 mutation in a gene involved in long QT syndrome
- and / or syncope (s) and QTc\> 460ms in the absence of other cause
- All ages
- No opposition from the patient
Exclusion
- None
- \-
Key Trial Info
Start Date :
March 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 12 2023
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT04728100
Start Date
March 22 2021
End Date
June 12 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chevalier
Bron, France, 69500